Skip to main content

Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.

Author(s): Lobo Abascal, Paloma; Luzar-Stiffler, Vesna; Giljanovic, Silvana; Howard, Brandon; Weiss, Herman; et al

Download
To refer to this page use: http://arks.princeton.edu/ark:/88435/pr1k16f
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLobo Abascal, Paloma-
dc.contributor.authorLuzar-Stiffler, Vesna-
dc.contributor.authorGiljanovic, Silvana-
dc.contributor.authorHoward, Brandon-
dc.contributor.authorWeiss, Herman-
dc.contributor.authorTrussell, James-
dc.date.accessioned2019-11-26T15:54:06Z-
dc.date.available2019-11-26T15:54:06Z-
dc.date.issued2016-06-26en_US
dc.identifier.citationLobo Abascal, Paloma, Luzar-Stiffler, Vesna, Giljanovic, Silvana, Howard, Brandon, Weiss, Herman, Trussell, James. (2016). Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 21 (1), 88 - 91. doi:10.3109/13625187.2015.1059416en_US
dc.identifier.issn1362-5187-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/pr1k16f-
dc.description.abstractRegulatory agencies in the United States (US) and Europe differ in requirements for defining pregnancies after the last dose of oral contraceptive, sometimes resulting in discrepant Pearl Indices (PIs) for the same product despite identical clinical data. This brief report highlights one such example, a 91-day extended-regimen combined oral contraceptive (COC).The US- and European-based PI methodologies were compared for a 91-day extended-regimen COC consisting of 84 days of active levonorgestrel/EE 150 μg/30 μg tablets, followed by seven days of EE 10 μg tablets in place of placebo.At the times of approval of the 91-day extended-regimen COC in the US and Europe, the requirements for defining 'on-treatment' pregnancies differed (14-day vs. 2-day rule, respectively). This difference resulted in a higher PI in the US- vs. European-based calculation (1.34 and 0.76, respectively). The differences in the PI should not be interpreted as the extended-regimen COC being less effective in preventing pregnancy in the US compared with Europe.en_US
dc.format.extent1 - 5en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraceptionen_US
dc.rightsAuthor's manuscripten_US
dc.titleDifferences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.en_US
dc.typeJournal Articleen_US
dc.identifier.doidoi:10.3109/13625187.2015.1059416-
dc.identifier.eissn1473-0782-
pu.type.symplectichttp://www.symplectic.co.uk/publications/atom-terms/1.0/journal-articleen_US

Files in This Item:
File Description SizeFormat 
Differences in Reporting Pearl Indices.pdf42.38 kBAdobe PDFView/Download


Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.